Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions
NCT00130494
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
97
Enrollment
OTHER
Sponsor class
Stopped
Low recruitment
Conditions
Breast Cancer
Neoplasm Metastasis
Interventions
DRUG:
Zoledronic acid
Sponsor
Spanish Breast Cancer Research Group
Collaborators
[object Object]